Last edition
News about "Milestone Pharmaceuticals"
Milestone's Etripamil Nasal Spray Wins China NMPA Approval for PSVT
Milestone Pharmaceuticals’ etripamil nasal spray receives China NMPA approval for PSVT, triggering a USD 2 million payment and expanding access in Greater China.
Milestone Pharmaceuticals | 05/09/2026 | By News Bureau
Milestone Pharmaceuticals Enrolls First Patient in Phase 3 Trial of Etripamil for AFib-RVR
Milestone Pharmaceuticals has begun its Phase 3 ReVeRA-301 trial to evaluate self-administered etripamil nasal spray for acute AFib-RVR, targeting rapid ventricular rate reduction and symptom relief.
Milestone Pharmaceuticals | 24/08/2026 | By News Bureau | 102
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy